======= CARNS1 =======
== Gene Information ==
* **Official Symbol**: CARNS1
* **Official Name**: carnosine synthase 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57571|57571]]
* **UniProt**: [[https://www.uniprot.org/uniprot/A5YM72|A5YM72]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CARNS1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CARNS1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/613368|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Catalyzes the synthesis of carnosine and homocarnosine. Carnosine is synthesized more efficiently than homocarnosine. {ECO:0000269|PubMed:20097752}.
No Pfam Domain information is available for this gene.
|carnosine biosynthetic process|
|homocarnosine synthase activity|
|carnosine synthase activity|
|carnosine metabolic process|
|histidine catabolic process|
|imidazole-containing compound catabolic process|
|histidine metabolic process|
|imidazole-containing compound metabolic process|
|FMN binding|
|aromatic amino acid family catabolic process|
|aromatic amino acid family metabolic process|
|cellular modified amino acid biosynthetic process|
|alpha-amino acid catabolic process|
|cellular amino acid catabolic process|
|cellular modified amino acid metabolic process|
|alpha-amino acid metabolic process|
|ATPase activity|
|carboxylic acid catabolic process|
|organic acid catabolic process|
|carboxylic acid biosynthetic process|
|organic acid biosynthetic process|
|cellular amino acid metabolic process|
|peptide biosynthetic process|
|heterocycle catabolic process|
|cellular nitrogen compound catabolic process|
|small molecule catabolic process|
|aromatic compound catabolic process|
|cellular component|
|organic cyclic compound catabolic process|
|drug metabolic process|
|amide biosynthetic process|
|peptide metabolic process|
|small molecule biosynthetic process|
|cellular amide metabolic process|
|carboxylic acid metabolic process|
|oxoacid metabolic process|
|organic acid metabolic process|
|organonitrogen compound catabolic process|
|organonitrogen compound biosynthetic process|
|ATP binding|
|cellular nitrogen compound biosynthetic process|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-1.75|
|[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|-1.73|
|[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|-1.7|
|[[:results:exp280|Daidzin 10μM R06 exp280]]|1.71|
|[[:results:exp465|Cannabidiol 13μM R08 exp465]]|1.77|
|[[:results:exp466|Cannabidiol 20μM R08 exp466]]|1.84|
|[[:results:exp345|Cidofovir 10μM R07 exp345]]|1.87|
^Gene^Correlation^
|[[:human genes:h:hgc6.3|HGC6.3]]|0.705|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5427
* **Expression level (log2 read counts)**: 0.61
{{:chemogenomics:nalm6 dist.png?nolink |}}